» Articles » PMID: 24565622

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the 2005-2006 National Health and Nutrition Examination Survey

Overview
Date 2014 Feb 26
PMID 24565622
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Allergen exposure is associated with increased specific IgE (sIgE), and allergen exposure plus sensitization is predictive of asthma outcomes. However, it is not known if sIgE is predictive of asthma outcomes in the absence of exposure data.

Objective: To investigate whether IgE to indoor allergens is predictive of and has a dose-response relationship with asthma emergency department (ED) visits and wheeze.

Methods: In the 2005-2006 National Health and Nutrition Examination Survey, 351 children and 390 adults reported current asthma. Continuous sIgE to 9 indoor allergens were considered. Asthma morbidity in the past year was measured by wheezing. Health care utilization was defined as any asthma ED visits in the past year.

Results: Analyses were adjusted for race, age, education, poverty index ratio and (in adults) tobacco use. In children, ED visits were associated with cockroach (odds ratio [OR] 1.5 [95% CI, 1.1-2 .1), rat (OR 1.9 [95% CI, 1.2-2.8]), and Aspergillus (OR 1.6 [95% CI, 1.001-2.60]). Continuous Aspergillus (OR 1.5 [95% CI, 1.04-2.1), Alternaria (OR 1.4 [95% CI, 1.1-1.6]), and total IgE (OR 1.2 [95% CI, 1.1-1.4]) were associated with wheeze in children. Adult ED visits were associated with sIgE for dust mites (Dermatophagoides pteronyssinus OR 1.6 [95% CI, 1.3-2.1]; Dermatophagoides farinae OR 1.6 [95% CI, 1.3-1.9]), total IgE (OR 1.4 [95% CI, 1.04- 1.9]), and the sum of sIgEs (OR 1.6 [95% CI, 1.2-2.2]).

Conclusions: Sensitization to particular indoor environmental allergens was found to be a risk factor for wheeze and asthma ED visits. These outcomes increased as the concentration of sIgE to these allergens increased.

Citing Articles

Associations of aeroallergen testing with reduced oral corticosteroid bursts among adults with asthma.

Gleeson P, Morales K, Buckey T, Fadugba O, Apter A, Christie J J Allergy Clin Immunol Glob. 2024; 4(1):100348.

PMID: 39583037 PMC: 11585680. DOI: 10.1016/j.jacig.2024.100348.


Fungal lung disease.

Jaggi T, Agarwal R, Tiew P, Shah A, Lydon E, Hage C Eur Respir J. 2024; 64(5).

PMID: 39362667 PMC: 11602666. DOI: 10.1183/13993003.00803-2024.


Outdoor aeroallergen impacts on asthma exacerbation among sensitized and nonsensitized Philadelphia children.

De Roos A, Senter J, Schinasi L, Huang W, Moore K, Maltenfort M J Allergy Clin Immunol Glob. 2024; 3(3):100248.

PMID: 38645670 PMC: 11024998. DOI: 10.1016/j.jacig.2024.100248.


Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.

Agarwal R, Sehgal I, Muthu V, Denning D, Chakrabarti A, Soundappan K Eur Respir J. 2024; 63(4).

PMID: 38423624 PMC: 10991853. DOI: 10.1183/13993003.00061-2024.


Aspergillus Sensitization and Allergic Bronchopulmonary Aspergillosis in Asthmatic Children: A Systematic Review and Meta-Analysis.

Agarwal R, Muthu V, Sehgal I, Dhooria S, Prasad K, Soundappan K Diagnostics (Basel). 2023; 13(5).

PMID: 36900068 PMC: 10001349. DOI: 10.3390/diagnostics13050922.